• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. 脱细胞异体真皮与混合微粒复合移植再造阴道的临床疗效评价

脱细胞异体真皮与混合微粒复合移植再造阴道的临床疗效评价

来源 :2014中华医学会整形外科分会第十三次全国学术交流会 | 被引量 : 0次 | 上传用户：godzerovwx
【摘 要】
：
目的 观察在混合微粒移植的基础上加用脱细胞异体真皮的阴道再造术的远期效果.方法 自2006年7月至2013年6月,共收治67例先天性无阴道患者.年龄16～39岁,平均24岁.根据患者意愿选择术式进行分组,真皮组20例,混合微粒组47例,严格按照分组结果实施手术操作.所有患者术后均获得随访,随访时间1-3年.患者需于术后1、3、6、12月返院复查.术后功能评价内容包括：①测量再造阴道的深度、周径、容
【作 者】
：
周宇 李强 李森恺 周传德 李峰永 曹玉娇 张思娅 魏蜀一 赵阳 
【机 构】
：
中国医学科学院整形外科医院整形十科
【出 处】
：
2014中华医学会整形外科分会第十三次全国学术交流会
【发表日期】
：
2014年8期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　目的 观察在混合微粒移植的基础上加用脱细胞异体真皮的阴道再造术的远期效果.方法 自2006年7月至2013年6月,共收治67例先天性无阴道患者.年龄16～39岁,平均24岁.根据患者意愿选择术式进行分组,真皮组20例,混合微粒组47例,严格按照分组结果实施手术操作.所有患者术后均获得随访,随访时间1-3年.患者需于术后1、3、6、12月返院复查.术后功能评价内容包括：①测量再造阴道的深度、周径、容积,来反映再造阴道的大体观.(②记录创面上皮化时间及脱离模具时间.③对已有性生活患者应用女性性功能问卷(Female Sexual Function Index,FSFI)进行性功能评分.
其他文献
Genome-wide DNA methylation variationsin mastiticcows naturally infectedbyStaphylococcus aureus
With unprecedented advances in biotechnology epigenetic modification is considered to be a flexible and substantial regulatory factor in pathogenesis.DNA methylation, an important and stable epigeneti
会议
S.aureusmastitisGenome-wide DNA methylationMeDIP-chip
Epigenetic Alterations during Chronic Colitis Malignant Transformation
Besides the canonical and non-canonical Wnt pathway to colorectal cancer, chronic colitis is strongly associated with colorectal cancer formation.However, the mechanisms of how colitis develops and ho
会议
MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and stemness of glioma stem cells via rea
Glioma stem cells (GSCs) exhibit stem cell properties and high resistance to radiotherapy.Reactive oxygen species (ROS) play pivotal roles in tumorigenesis, metastasis, and therapeutic resistance of c
会议
microRNA-153Nrf-2GPx1radiosensitivityGlioma stem cellsROS
Upregulation of miR-205 Promotes Radioresistance in Esophageal Cancer
Background:Esophageal cancer (EC) is one of the most aggressive malignant tumors, ranking eighth by global morbidity and sixth by global mortality among all types of cancers.Radiation therapy, one of
会议
miR-205RadioresistanceEsophageal CancerSp1PTEN
The Epigenetic Silencing of Metastasis Suppressor Protein p66shc in Small Cell Lung Cancer
Epigenetic dysregulation and consequent activation and/or silencing of tumor related genes are now believed to play critical roles during all stages of tumorigenesis, p66Shc, an important metastasis s
会议
p66ShcAiolosChromosome Conformation Captureanoikis resistance
Cancer-testis antigen OY-TES-1: expression and functional relevance in glioma
Background: OY-TES-1, a member of the cancer testis antigen (CTA) family, was originally identified as a proacrosin binding protein sp32 precursor involved in spermatogenesis and sperm capacitation.Th
会议
Epigenetic and Proteomic Analyses of Cadmium-Induced Adaptation and Carcinogenesis in Lung Cells
Cadmium (Cd), a non-essential toxic metal, stealthily enters the cells by utilizing the essential metal importing pathways.Cd and Cd compounds have been classified as group I carcinogens by the Intern
会议
Effect of DNA methylation inhibitor on RARβ genes expression in Gastric Cancer
Background Gastric cancer remains the fourth most commonly diagnosed cancer and is the second leading cause of global cancer mortality.Late detection is a major contributor to high mortality rates owi
会议
DNA methylationRARBGene expressionMethylation inhibitorGastric cancer
MiR-491-3p/mTORC2/FOXO1 regulatory loop mediates chemotherapeutic sensitivity via targeting mTORC2 c
To investigate miRNAs involved in the resistance of tongue cancer cells to chemotherapy, the miRNAs profiles between PYM (pingyangmycin) induced multidrug-resistant tongue cancer cell line Tca8113/PYM
会议
tongue cancermiR-49103pRictormTORC2drug resistance
应用预扩张胸三角皮瓣修复全面及颈部瘢痕的治疗体会
目的 探讨应用预制扩张胸三角等联合皮瓣修复全面及颈部瘢痕的效果。方法 在胸三角至肩胛区植入600～800ML柱形扩张器,经3至4个月注水,注水后容量为1500～2000ML,获得足够的皮肤后,切除面颈部瘢痕,创面应用扩张后胸三角皮瓣转移修复,4周后断蒂,利用蒂部皮瓣修复剩余瘢痕切除后的创面。此后为改善皮瓣厚度、修复剩余创面,在转移于面部的皮瓣下应用70ML～100ML柱形扩张器,分别进行1至3次的
会议